Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-16 Sale | 2024-01-17 5:31 pm | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 20,563 | $0.68601 | $14,106 | 19,257 (Direct) | View |
| 2024-01-11 Sale | 2024-01-12 5:00 pm | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 11,808 | $0.84819 | $10,015 | 11,841 (Direct) | View |
| 2023-01-17 Sale | 2023-01-17 9:16 pm | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 2,159 | $1.858 | $4,011 | 3,491 (Direct) | View |
| 2023-01-11 Sale | 2023-01-12 9:01 pm | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 11,292 | $1.7199 | $19,421 | 12,191 (Direct) | View |
| 2023-01-04 Sale | 2023-01-04 9:01 pm | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 876 | $1.694 | $1,484 | 1,361 (Direct) | View |
| 2022-01-18 Sale | 2022-01-18 9:02 pm | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 2,121 | $3.1918 | $6,770 | 3,529 (Direct) | View |
| 2022-01-11 Sale | 2022-01-13 9:01 pm | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 4,624 | $3.5544 | $16,435 | 1,383 (Direct) | View |
| 2022-01-04 Sale | 2022-01-05 9:05 pm | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 849 | $4.0642 | $3,451 | 1,388 (Direct) | View |
| 2021-01-19 Sale | 2021-01-19 9:01 pm | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 2,111 | $5.6695 | $11,968 | 3,539 (Direct) | View |
| 2021-01-12 Sale | 2021-01-12 9:00 pm | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 841 | $6.1522 | $5,174 | 1,396 (Direct) | View |
| 2021-01-04 Sale | 2021-01-05 9:00 pm | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 845 | $5.3279 | $4,502 | 1,392 (Direct) | View |
| 2020-01-14 Sale | 2020-01-15 8:03 pm | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 911 | $5.1347 | $4,678 | 1,326 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-15 Option Award | 2024-01-17 5:01 pm | N/A 2034-01-15 | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 3,109,848 | $0 | 3,109,848 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-17 9:03 pm | N/A 2033-01-17 | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 1,914,672 | $0 | 1,914,672 (Direct) | View |
| 2022-01-12 Option Award | 2022-01-13 9:02 pm | N/A 2032-01-12 | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 2,581,968 | $0 | 2,581,968 (Direct) | View |
| 2021-01-11 Option Award | 2021-01-11 9:02 pm | N/A 2031-01-11 | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 1,329,528 | $0 | 1,329,528 (Direct) | View |
| 2020-01-16 Option Award | 2020-01-17 9:48 pm | N/A 2030-01-16 | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 337,200 | $0 | 337,200 (Direct) | View |
Ownership | 2020-01-13 8:02 pm | N/A N/A | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 0 | $0 | 805,883 (Direct) | View |